PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer

Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway

(2015) Shuichi Fukuda et al.   ANNALS OF SURGICAL ONCOLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinicopathological Characteristics of Gynecological Cancer Associated with Hypoxia-Inducible Factor 1α Expression: A Meta-Analysis Including 6,612 Subjects

(2015) Yue Jin et al.   PLoS One

The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer

(2015) G.R. Leisching et al.   TOXICOLOGY

High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer

(2015) Yang Lin et al.   Journal of Cancer

HIF-1 Signaling in Drug Resistance to Chemotherapy

(2014) N.A. Warfel et al.   CURRENT MEDICINAL CHEMISTRY

mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review

(2014) Nader Husseinzadeh et al.   GYNECOLOGIC ONCOLOGY

Systems biology of cisplatin resistance: past, present and future

(2014) L Galluzzi et al.   Cell Death & Disease

Immunohistochemical Expression of RAGE and Its Ligand (S100A9) in Cervical Lesions

(2013) Xuejie Zhu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc

(2013) K. Hatano et al.   MOLECULAR CANCER RESEARCH

Prognostic and Predictive Significance of MYC and KRAS Alterations in Breast Cancer from Women Treated with Neoadjuvant Chemotherapy

(2013) Cynthia Brito Lins Pereira et al.   PLoS One

Proteomic Identification of Neoadjuvant Chemotherapy-Related Proteins in Bulky Stage IB-IIA Squamous Cervical Cancer

(2013) Shuangwei Zou et al.   Reproductive Sciences

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB–IIA cervical cancer treated with neoadjuvant chemotherapy

(2012) LanYing Jin et al.   GYNECOLOGIC ONCOLOGY

Hypoxia-inducible factor-1 as a therapeutic target in cancer

(2012) Ceen-Ming Tang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China

(2012) Yang Yuan et al.   MEDICAL ONCOLOGY

C-myc as a predictive marker for chemotherapy in metastatic breast cancer

(2011) Nataša Todorović-Raković et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

(2011) Q. Sun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice

(2010) Hua-shan Shi et al.   CANCER SCIENCE

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

(2010) Wenhao Guo et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines

(2009) E. Martinez-Balibrea et al.   MOLECULAR CANCER THERAPEUTICS

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1)in vitroandin vivoby increasing the activity of the p-glycoproteinviaactivation of p38

(2008) Christoph Sauvant et al.   INTERNATIONAL JOURNAL OF CANCER

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials

(2007) Anand Rajeswaran et al.   LUNG CANCER

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

(2007) Leri S. Faried et al.   MOLECULAR CARCINOGENESIS